RHYTHM PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

Rhythm Pharmaceuticals, Inc. (the "Company") will discuss information in the attached presentation during meetings with investors in San Francisco, California beginning Monday, January 13, 2020 through Thursday, January 16, 2020 to coincide with the 38th Annual J.P. Morgan Healthcare Conference. A copy of the materials is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The Company undertakes no obligation to update, supplement or amend the materials attached hereto.

The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information in this Item 7.01 and the exhibit hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.                   Description

  99.1          Company Presentation dated January 2020




  2

© Edgar Online, source Glimpses